NYC-WTC_000195164

NYC 9/11 Public Portal Document

. ASBESTOS REPROTEXT ® System Page 21 of 27

in the North American insulator cohort, 1981 to 1991. Am J Respir Crit Care Med 1997; 156:101-198. 227. McCann M: EPA orders schools to identify asbestos-containing material. Art Hazard News 1982; 5:2. 228. McDonald JC, Armstrong B, Case B et al: Mesothelioma and asbestos fiber type. Evidence from lung tissue analyses. Cancer 1989; 63:1544-1547. 229. McDonald JC, Sebastien P, Case B et al: Ferruginous body counts in sputum as an index of past exposure to mineral fibres. Am Occup Hyg 1992; 36:271-282. 230. McLarty JW, Greenberg SD, Hurst GA et al: The clinical significance of ferruginous bodies in sputa. J Occup Med 1980; 22:92-96. 231. McLoud TC, Woods BO, Carrington CB et al: Diffuse pleural thickening in an asbestos- exposed population: prevalence and causes. Am J Roentgenol 1985; 144:9-18. 232. McLure M & Poole C: Asbestos and kidney cancer: the evidence supports a causal association. Am J Ind Med 1990; 17:647-648. 233. Metintas M, Ozdemir N, Hillerdal G et al: Environmental asbestos exposure and malignant pleural mesothelioma. Resp Med 1999; 93:349-355. 234. Miller A & Miller JA: Diffuse thickening superimposed on circumscribed pleural thickening related to asbestos exposure. Am J Ind Med 1993; 23:859-871. 235. Miller A, Teirstein AS & Selikoff IJ: Ventilatory failure due to asbestos pleurisy. Am J Med 1983; 75:911-919. 236. Miller A: Chronic pleuritic pain in four patients with asbestos-induced pleural fibrosis. Br J Ind Med 1990; 47:147-153. 237. Mollo F, Piolatto G, Bellis D et al: Asbestos exposure and histologic cell types of lung cancer in surgical and autopsy series. Internal J Cancer 1990; 46:576-580. 238. Mossman BT & Gee JBL: Asbestos-related diseases. N Engl J Med 1989; 320:1721- 1730. 239. Mossman BT, Bignon J, Com M et al: Asbestos: scientific developments and implications for public policy. Science 1990; 247:294-301. 240. Mowe G, Gylseth B, Hartveit F et al: Occupational asbestos exposure, lung-fiber concentration and latency time in malignant mesothelioma. Scand J Work Environ Health 1984; 10:293-298. 241. Murphy RLH, Ferris BG Jr, Burgess WA et al: Effects of low concentrations of asbestos. N Engl J Med 1971;23:1271-1278. 242. Murray R: Asbestos: a chronology of its origins and health effects. Br J Ind Med 1990; 47:361-365. 243. Muscat JE & Wynder EL: Cigarette smoking, asbestos expsure, and malignant mesothelioma. Cancer Res 1991; 51:2263-2267. 244. Nash DR, Fortson NG, McLarty JW et al: Serum protein concentrations and respiratory tract abnormalities following short-term exposure to amosite: a comparison between former asbestos workers and unexposed controls. J Toxicol Environ Health 1981; 7:733- 744. 245. Nelson HH, Christiani DC, Wiencke JK et al: k-ras mutation and occupational asbestos exposure in lung adenocarcinoma: asbestos-related cancer without asbestosis. Cancer Res 1999; 59:4570-4573. 246. Neri S, Boraschi P, Antonelli A et al: Pulmonary function, smoking habits, and high resolution computed tomography (HRCT) early abnormalities of lung and pleural fibrosis in shipyard workers exposed to asbestos. Am J Ind Med 1996; 30:588-595. 247. Neuberger M & Kundi M: Individual asbestos exposure: smoking and mortality — a cohort study in the asbestos cement industry. Br J Ind Med 1990; 47:615-620. 248. Newhouse ML: Asbestos-related diseases. Practitioner 1983; 227:1399.

http://www.tomescps.eom/DATA/RE/RE356.HTM?Top=Yes 1/4/2002

CITY_21MC100_011105164

NYC-WTC_000195184